Literature DB >> 18018402

Single, percutaneous, femoral venous cannulation for cardiopulmonary bypass.

William Riley1, Daniel FitzGerald, Lawrence Cohn.   

Abstract

Percutaneous femoral venous cannulation for cardiopulmonary bypass has emerged as an indispensable technique in the management of cardiac surgical procedures requiring cardiopulmonary bypass. A review of cases at Brigham and Women's Hospital (Boston, MA, USA) relying solely on percutaneous femoral venous cannulation for venous return to the heart-lung machine demonstrated achievable blood flow and complexity of case-load. Operations performed in this manner include, but are not limited to, coronary artery bypass grafting (CABG), valve, CABG/valve, and aortic procedures. Minimally invasive procedures and re-operations comprise a portion of each group. Complications of cardiopulmonary bypass and site-related complications were considered. Percutaneous femoral venous cannulation is a safe method to provide most patients with adequate venous return to perform any cardiac surgery. Patients demanding greater flow than this method will provide, may require a second venous cannula at some time during cardiopulmonary bypass.

Entities:  

Mesh:

Year:  2007        PMID: 18018402     DOI: 10.1177/0267659107083021

Source DB:  PubMed          Journal:  Perfusion        ISSN: 0267-6591            Impact factor:   1.972


  3 in total

Review 1.  Cannulation Strategies and Pitfalls in Minimally Invasive Cardiac Surgery.

Authors:  Mahesh Ramchandani; Odeaa Al Jabbari; Walid K Abu Saleh; Basel Ramlawi
Journal:  Methodist Debakey Cardiovasc J       Date:  2016 Jan-Mar

2.  Direct cannulation of the infrahepatic vena cava for emergent cardiopulmonary bypass support.

Authors:  Raja R Gopaldas; Kirti P Patel; James J Livesay; Denton A Cooley
Journal:  Tex Heart Inst J       Date:  2009

3.  Hydrodynamic Evaluations of Four Mock Femoral Venous Cannulas.

Authors:  Türker Şahin; Murat Tezer; Levent Cerit
Journal:  Braz J Cardiovasc Surg       Date:  2018 Sep-Oct
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.